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Letter to editor  
 
Suppository diclofenac instead of intravenous meperidine  
for postoperative management  
 
Sir 
Shivering is the most common complication after 
anaesthesia and postoperative pain is another important 
impediment to recovery from surgery. Postoperative pain 
and shivering are two postoperative challenging components 
(1). Prevention of postoperative pain and post anaesthetic 
shivering should be considered and managed as two 
important components which demonstrably improve the 
patient’s outcome. 
Decisions on postoperative analgesia and post anaesthetic 
shivering should be based on the evidence of efficacy and 
safety. Various opioid like meperidine and buprenorphine; 
and non-opioid agents including clonidine and non-steroidal 
anti-inflammatory drugs (NSAIDs) are used to prevent, 
control and treat postoperative pain and shivering but they 
are not without any side effects and it will be surprising if it 
all works on a single part mechanism (1-3). Meperidine 
hydrochloride that is known as pethidine outside the United 
States is a synthetic opiate agonist belonging to the 
phenylpiperidine class. Meperidine in particular, is 
remarkably effective in postoperative shivering and pain 
treatment when given intravenously. Meperidine is known as 
a standard regimen for postanaesthetic shivering suppression 
and pain management (2, 3). Meperidine has a variety of side 
effects. Owing to the wide range of side effects with 
meperidine, its replacement with other analgesics has always 
been considered.  
Sodium diclofenac is from NSAIDs category which has 
been shown to have analgesic affects in various conditions. 
Sodium diclofenac offers the advantages that it could inhibit 
prostaglandin biosynthesis by blocking the cyclooxygenase 
enzyme. By reducing the production of these agents, the 
feeling of pain may decrease in the peripheral nervous 
system; although a central anti-nociceptive effect has also 
been postulated for NSAIDS. opioids cannot remove 
chemical mediator of pain and by using meperidine, the 
patients still have an ambiguous feeling of pain. Moreover, 
sodium diclofenac neither causes respiratory depression, nor 
other meperidine side effects such as nausea, vomiting, 
decreased gastrointestinal (GI) motility, itching, respiratory  
 
depression, tachycardia and physical dependency and 
hemodynamic instability.
 
Sodium diclofenac like other 
NSAIDS has some GI effects and there is a theoretical risk 
of postoperative hemorrhage as it prolongs bleeding time and 
reduces platelet aggregation (1-4).  
Rashid et al. evaluated the efficacy of rectal diclofenac 
for analgesia after the surgery. Their results showed that pain 
in the study group was significantly less compared to the 
control group (5). A certain study assessed the efficacy of 
diclofenac on patients’ outcomes after cardiac surgery; it was 
concluded that sodium diclofenac has a significant opioid-
sparing effect after operation (3). 
 
The evaluation of preoperative rectal diclofenac for 
perioperative analgesia showed that it considerably delays 
the onset of postoperative pain, and is adequate as an 
analgesic for early postoperative period (1, 6, 7). We are 
conducting a multi central, prospective, double-blind, 
randomized clinical trial to evaluate the effects of 
prophylactic prescription of suppository diclofenac versus 
intravenous meperidine. 
We found out that the pre-emptive analgesic effect of 
sodium diclofenac is comparable to meperidine. The results 
support the important role of sodium diclofenac given before 
surgery to decrease the frequency of persistent pain after 
surgery. Our study showed that a single dose of 100 mg 
sodium diclofenac suppository could provide satisfactory 
analgesia immediately following surgery and decrease post 
operation shivering and its effect was comparable with 
meperidine effect. Our investigation highlights the role of 
preoperative administration of single dose of rectal 
diclofenac as a sole analgesic for early postoperative period. 
Because of a theoretical risk of post operative hemorrhage 
with the use of diclofenac, it prolongs the bleeding time and 
reduces platelet aggregation (7).  
There is a reluctance among the surgeons to use 
diclofenac due to its hypothetical risk of hematoma and the 
possibility of re-operation, but this concern may be 
overestimated by an investigator. However, in our study 
there was no case with extra intraoperative bleeding that 
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required active treatment; besides, in contrast with Legeby’s 
study we did not have excessive postoperative blood loss as 
compared with the control group (8). 
Although both suppositories, sodium diclofenac and 
meperidine effectively prevent shivering and pain after 
operation accompanied with an acceptable hemodynamic 
stability, suppository sodium diclofenac as an accessible and 
low-cost NSADs will be a valuable alternative for 
meperidine. Our observations highlight the role of 
preoperative administration of rectal diclofenac. We suggest 
preoperative administration of single dose of rectal 
diclofenac as a sole analgesic for early postoperative period. 
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